nuclear-medicine-radiation-therapy-2018-posters

Page 66

Journal of Medical Physics and Applied Sciences

ISSN: 2574-285X

I n t e r n a t i o n a l C o n f e r e n c e o n

Nuclear Medicine &

Radiation Therapy

Nuclear Medicine & Radiation Therapy 2018

O c t o b e r 0 1 - 0 2 , 2 0 1 8

S t o c k h o l m , S w e d e n

Introduction:

PET/CT with the radioactively labelled glucose analogue [18F]-fluoro-2-deoxy-2-D-glucose (

F-FDG) can be used to

quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the variation in humans

with and without liver disease. Standardised uptake value (SUV) of

F-FDG from static scans can substitute the hepatic systemic

clearance of

F-FDG from dynamic scans as measure of metabolic function.

Patient selection:

One year’s all oncological patient applicants to PET CT unit were selected. The correlation between ALT, AST

and SUV was samples. whole- SUV, average SUV multiplied by total metabolic liver volume) were calculated.

Results:

No significant differences were found SUV. SUV had higher with hepatosteotic patients. correlation coefficientsmetabolic

liver enzymes had non-significant variation.

Conclusions:

The reproducibility of

F-FDG PET/CT was good and SUV can of hepatic metabolic function. Total SUV of

F-FDG

is a promising tool for quantification of metabolic liver function in hepatosteoz.

Liver FDG metabolism and liver enzymes connections

Zerrin Dede

University of Katip Celebi, Turkey

J. med phys & appl sci 2018, Volume: 3

DOI: 10.21767/2574-285X-C1-003